Buzz Stocks: Caterpillar Inc., Advanced Micro Devices, Inc., and Vitae Pharmaceuticals Inc

Today's stocks to watch include Caterpillar Inc. (CAT), Advanced Micro Devices, Inc. (AMD), and Vitae Pharmaceuticals Inc (VTAE)

Mar 17, 2016 at 9:29 AM

U.S. stocks are set to open lower this morning, as traders react to blue-chip guidance, the latest economic data, and a dismal day in Europe. Among equities in focus are construction equipment producer Caterpillar Inc. (NYSE:CAT), chipmaker Advanced Micro Devices, Inc. (NASDAQ:AMD), and biotech stock Vitae Pharmaceuticals Inc (NASDAQ:VTAE).

Dow component CAT is down 2.1% in pre-market trading, after lowering its first-quarter earnings and revenue guidance, while leaving its full-year outlook unchanged. Caterpillar Inc. is ahead 9.4% in 2016, as of its Wednesday close at $74.34, and recently broke through its 200-day moving average for the first time since late 2014. However, today's expected pullback could delight the growing crop of option bears. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the equity's 50-day put/call volume ratio of 3.11 represents an annual high.

AMD is in talks to license its graphics technology to Intel Corporation (NASDAQ:INTC), according to Bloomberg reports, sending the chipmaker up 4.9% ahead of the open, after closing at $2.63 on Wednesday. Advanced Micro Devices, Inc. has been on an upswing since mid-February, and has added nearly 23% already in March. At the moment, 16 out of 20 brokerage firms rate the stock a "hold" or worse, leaving the door open for potential upgrades to propel AMD higher. Also, more than 16% of the security's available float is wrapped up in short interest -- worth almost 14 days of trading, at AMD's typical daily volume -- indicating plenty of buying power on the sidelines.

VTAE is poised to pop a whopping 74.7% at the open, after settling at $4.11 on Wednesday, thanks to a positive mid-stage trial of its experimental psoriasis drug and an upgrade to "buy" from Stifel. Vitae Pharmacueticals Inc gapped lower on earnings earlier this month, and hit a record low of $4.08 yesterday. The stock will have to more than double to make up for that post-earnings bear gap, but if it does, a recent batch of short sellers could begin backing off.

Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

Follow @Schaeffers

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade. Professional traders have rushed into the market and are making a mint. Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.